Design and synthesis of novel dihydroxyindole-2-carboxylic acids as HIV-1 integrase inhibitors

Antiviral Chemistry and Chemotherapy

Volumn 15, Issue 2, 2004, Pages 67-81

  Sechi, Mario ^a   Angotzi, Gianfranco ^a   Dallocchio, Roberto ^b   Dessi, Alessandro ^b   Carta, Fabrizio ^a   Sannia, Luciano ^a   Mariani, Alberto ^c   Fiori, Stefano ^c   Sanchez, Tino ^d   Movsessian, Leah ^d   Plasencia, Carmen ^d   Neamati, Nouri ^d  

^a UNIVERSITY OF SASSARI   (Italy)

^b CNR Consiglio Nazionale delle Ricerche   (Italy)

^c Dipartimento di Chimica   (Italy)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

5,6 dihydroxyindole 2 carboxylic acid; Catechol derivatives; Docking studies; HIV 1 integrase inhibitors

Indexed keywords

5,6 DIHYDROXYINDOLE 2 CARBOXYLIC ACID; CAFFEIC ACID PHENETHYL ESTER; DIMER; HYDROXYL GROUP; INTEGRASE INHIBITOR; PHENETHYLAMINE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CANCER CELL CULTURE; CATALYSIS; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG DESIGN; DRUG INHIBITION; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MELANOGENESIS; OVARY CARCINOMA; PRIORITY JOURNAL;

EID: 2342447273     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020401500203     Document Type: Article

References (50)

1. Asante-Appiah E & Skalka AM (1997) Molecular mechanism in retrovirus DNA integration. Antiviral Research 36:139-156.
2. Asante-Appiah E, Merkel G & Skalka AM (1998) Purification of untagged retroviral integrases by immobilized metal ion affinity chromatography. Protein Expression & Purification 12:105-110.
3. Brown PO (1998) In Retroviruses. Edited by JM Coffin, SH Hughes and HE Varmus. Cold Spring Harbor: Cold Spring Harbor Press, pp. 161-203.
4. Buolamwini JK & Assefa H (2002) CoMFA and CoMSIA 3D Docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site. Journal of Medicinal Chemistry 45:841-852.
5. Burke TR Jr, Fesen MR, Mazumder A, Wang J, Carothers A, Grumberger D, Driscoll J, Kohn K & Pommier Y (1995) Hydroxylated aromatic inhibitors of HIV-1 Integrase. Journal of Medicinal Chemistry 38:4171-4178.
6. Chang G, Guida WC & Still WC (1989) An internal coordinate Monte Carlo method for searching conformational space. Journal of the American Chemical Society 111:4379-4386.
7. Chen I-J, Neamati N & MacKerrel A (2002) Structure-based inhibitor design targeting HIV-1 integrase. Current Drug Targets 2:217-234.
8. D'Aquisto F, Carruccio M, D'Ischia M & Misuraca G (1995) 5,6-Dihydroxyindole-2-carboxylic acid, a diffusible melanin precursor, is a potent stimulator of lipopolysaccharide-induced production of nitric oxide by J774 macrophages. Life Science 57:401-406.
9. D'Ischia M, Napoletano A & Prota G (1996) [Oxidative polymerization of 5,6-dihydroxyindoles. Tracking the biosynthetic pathway to melanin pigments]. Gazzetta Chimica Italiana 126:783-789.
10. De Clercq E (2000) Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Medicinal Research Reviews 20:323-349.
11. Drake RR, Neamati N, Hong H, Pilon AA, Sunthankar P, Hume SD, Milne GWA & Pommier Y (1998) Identification of a nucleotide binding site in HIV-1 integrase. Proceedings of the National Academy of Science, USA 95:4170-4175.
12. Esposito D & Craigie R (1998) Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction. EMBO Journal. 17:5832-5843.
13. Farnet CM, Wang B, Hansen M, Lipford JR, Zalkow L, Robinson WE Jr, Siegel J & Bushman F (1998) Human immunodeficiency virus type 1 cDNA integration: new aromatic hydroxylated inhibitors and studies of the inhibition mechanism. Antimicrobical Agents & Chemotherapy 42:2245-2253.
14. Fesen MR, Kohn KW, Leteurtre F & Pommier Y (1993) Inhibitors of human immunodeficiency virus integrase. Proceedings of the National Academy of Science, USA 90:2399-2403.
15. Fesen MR, Pommier Y, Leteurtre F, Hiroguchi S, Young SD & Kohn KW (1994) Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochemical Pharmacology 48:595-608.
16. Gasteiger J & Marsili M (1980) Iterative partial equilization of orbital electronegativity - a rapid access to atomic charges. Tetrahedron 36:3219-3228.
17. Goldgur Y, Craigie R, Cohen GH, Fujiwara T, Yoshinaga T, Fujishita T, Sugimoto H, Endo T, Murai H & Davies DR (1999) Structure of the HIV-1 Integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design. Proceedings of the National Academy of Science, USA 96:13040-13043.
18. Hazuda DJ, Felock PJ, Hastimgs JC, Pramanick B & Wolfe AL (1997) Differential divalent cation requirements uncouple the assembly and catalityc reactions of human immunodeficiency virus type 1 integrase. Journal of Virology 71:7005-7011.
19. Hemetsberger H, Knittel D & Weidmann H (1970) [Enazides Part 3: Thermolysis of α-azidocinnamates; synthesis of indole derivatives]. Monatschefte für Chemie 101:161-165. German.
20. Jenkins TM, Esposito D, Engelman A & Craigie R (1997) Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking. EMBO Journal 16:6849-6859.
21. Knittel D (1985) Improved synthesis of α-azidocinnamates and 2H-azirines. Synthesis 186-188.
22. LaFemina RL, Graham PL, LeGrow K, Hastings JC, Wolfe A, Young SD, Emini EA & Hazuda DJ (1995) Inhibition of human immunodeficiency virus integrase by bis-catechols. Antimicrobical Agents & Chemotherapy 39:320-324.
23. Macromodel, version 6.0; Columbia University, New York, 1997.
24. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK & Olson AJ (1998) Automated docking using a Lamarckian genetic algorithm as an empirical binding free energy function. Journal of Computational Chemistry 19:163-166.
25. Morris GM, Goodsell DS, Huey R & Olson A (1996) Distributed automated docking of flexible ligands to proteins: Parallel application of AutoDock 2.4*. Journal of Computational-Aided Molecular Design 10:293-304.
26. Neamati N (2001) Structure-based HIV-1 integrase inhibitor design: a future perspective. Expert Opinion on Investigational Drugs. 10:281-296.
27. Neamati N (2002) Patented small molecule inhibitors of HIV-1 integrase: a ten-year saga. Expert Opinion Therapeutic Patents 12:709-724.
28. Neamati N, Marchand C & Pommier Y (2000) HIV-1 integrase inhibitors: past, present, and future. In Advances in Pharmacology, vol. 49. Academic Press; pp. 147-165.
29. Neamati N, Marchand C, Winslow H & Pommier Y (2001) Human immunodeficiency virus type 1 integrase-targeted inhibitor design. Antiretroviral Therapy 5:87-104.
30. Neamati N, Lin Z, Karki RG, Orr A, Cowansage K, Strumberg D, Pais CGP, Voigt JH, Nicklaus MC, Winslow HE, Zhao H, Turpin JA, Yi J, Skalka AM, Burke TR Jr & Pommier Y (2002) Metal-dependent inhibition of HIV-1 integrase. Journal of Medicinal Chemistry 45:5661-5670.
31. Nicklaus MC, Neamati N, Hong H, Mazumder A, Sunder S, Chen J, Milne GWA & Pommier Y (1997) HIV-1 Integrase pharmacophore: discovery of inhibitors through three-dimensional database searching. Journal of Medicinal Chemistry 40:920-929.
32. Nicolaus RA (1968). In Melanins. Paris: Hermann, pp. 155-215.
33. Nicolaus RA, Piattelli M & Fattorusso E (1964) The structure of melanins and melanogenesis. IV. On some natural melanins. Tetrahedron 20:1163-1172.
34. Ouali M, Laboulais C, Leh H, Gill D, Xhuvani E, Zouhiri F, Desmaele D, d'Angelo J, Auclair C & Mouscadet JF (2000) Tautomers of styrylquinoline derivatives containing a methoxy substituent: computation of their population in aqueous solution and their interaction with RSV integrase catalytic core. Acta Biochimica Polonica 47:11-22.
35. Pais GCG & Burke TR Jr (2002) Novel aryl diketo-containing inhibitors of HIV-1 integrase. Drugs of the Future 27:1101-1111.
36. Polanski J, Zohuri F, Jeanson L, Desmaele D, d'Angelo J, Mouscadet JF, Gieleciak R, Gasteiger J & Le Bret M (2002) Use of the Kohonen neural network for rapid screening of ex vivo anti-HIV activity of styrylquinolines. Journal of Medicinal Chemistry 45:4647-4654.
37. Pommier Y, Marchand C & Neamati N (2000) Retroviral integrase inhibitors year 2000: update and perspectives. Antiviral Research 47:139-148.
38. Pommier Y, Pilon A, Bajaj K, Mazumder A & Neamati N (1997) HIV-1 integrase as a target for antiviral drugs. Antiviral Chemistry & Chemotherapy 8:483-503.
39. Prota G (1992). In Melanins & Melanogenesis. San Diego: Academic Press, pp. 93-148.
40. Robinson WE Jr, Reinicke MG, Abdel-Malek S, Jia Q & Chow SA (1996) Inhibitors of HIV-1 replication that inhibit HIV integrase. Proceedings of the National Academy of Science, USA 93:6326-6331.
41. Simpson J, Forrester R, Tisdale MJ, Billington DC & Rathbone DL (2003) Effect of catechol derivatives on cell growth and lipoxygenase activity. Bioorganic & Medicinal Chemistry Letters 13:2435-2439.
42. Stanwell C, Ye B, Yuspa SH & Burke TR Jr (1996) Cell protein cross-linking by erbstatin and related compounds. Biochemical Pharmacology 52:475-480.
43. Sotriffer CA, Ni H & McCammon AJ (2000) Active site binding modes of HIV-1 Integrase inhibitors. Journal of Medicinal Chemistry 43:4109-4117.
44. Sotriffer CA, Ni H & McCammon AJ (2000) HIV-1 Integrase inhibitor interactions at the active site: prediction of binding modes unaffected by crystal packing. Journal of the American Chemical Society 122:6136-6137.
45. SYBYL, version 6.2; Tripos Inc., St Louis, Mo., USA, 2001.
46. Tsukamoto K, Palumbo A, D'Ischia M, Hearing VJ & Prota G (1992) 5,6-Dihydroxyindole-2-carboxylic acid is incorporated in mammalian melanin. Biochemical Journal 286:491-495.
47. Weislow OW, Kiser R, Fine D, Bader J, Shoemaker RH & Boyd MR (1989) New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS antiviral activity. Journal of National Cancer Institute 81:577-586.
48. Yi J, Asante-Appiah E & Skalka AM (1999) Divalent cations stimulate preferential recognition of a viral DNA end by HIV-1 integrase. Biochemistry 38:8458-8468.
49. Zhao H, Neamati N, Mazumder A, Sunder S, Pommier Y & Burke TR Jr (1997) Hydrazide-containing inhibitors of HIV-1 Integrase. Journal of Medicinal Chemistry 40:1186-1194.
50. Zhang X, Neamati N, Lee YK, Orr A, Brown RD, Whitaker N, Pommier Y & Burke TR Jr (2001) Arylisothiocyanate-containing esters of caffeic acid designed as affinity ligands for HIV-1 integrase. Bioorganic & Medicinal Chemistry 9:1649-1657.